All Comments by Alexei Koudinov

  1. What evidence would prove the amyloid hypothesis? Towards rational drug treatments for Alzheimer's disease.
  2. Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease.
  3. Explaining the cause of the amyloid burden in Alzheimer disease.
  4. Characterization of neuronal dystrophy induced by fibrillar amyloid beta: implications for Alzheimer's disease.
  5. Continuing strategies for inhibiting Alzheimer's gamma-secretase.
  6. Human antibodies against amyloid beta peptide: a potential treatment for Alzheimer's disease.
  7. Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: the emerging role of oligomeric assemblies.
  8. Neuroscience. Long-awaited technique spots Alzheimer's toxin.
  9. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.
  10. Alzheimer beta-amyloid peptides: structures of amyloid fibrils and alternate aggregation products.
  11. Alzheimer's Disease: Genes, Pathogenesis and Risk Prediction.
  12. Peptide aggregation in neurodegenerative disease.
  13. Abeta42 plasma in the diagnosis of Alzheimer's disease.
  14. Tau, phospho-tau and Ab42 in cerebrospinal fluid in Alzheimer's disease.
  15. Cerebrospinal fluid 24S-hydroxycholesterol is increased in Alzheimer's disease compared to healthy controls.